DalCanto and VanderLugt. 2005. “The Role Of Astrocytes, Oligodendrocytes, Microglia and Endothelial Cells in TMEV Infection.”   Experimental Models of Multiple Sclerosis, eds., E. Lavi and S. Constantinescu.  London: Kulwer Academic Publishers, forthcoming.

Olson, J. K., C. L. Vanderlugt, and S. D. Miller. 2005. “Role of T cells and the innate immune system in the pathogenesis of Theiler’s virus demyelinating disease.”  Experimental Models of Multiple  Sclerosis, eds., E. Lavi and S. Constantinescu.  London: Kulwer Academic Publishers, forthcoming.

Howard, L. M., A. P. Kohm, C. L. Vanderlugt, and S. D. Miller.  2005. "Therapeutic treatment of established EAE by blockade of the B7/CD28 and/or CD40/CD40L costimulatory pathways." Current Drug Targets Inflammation and Allergy  4(2): 205-16.

McMahon EJ, Bailey SL, Castaneda CV, Waldner H, Miller SD.  2005.  "Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis."  Nat Med. 11(3): 335-9.

Miller, S. K., and C. L. Vanderlugt-Castaneda. “Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) and autoimmunity.”  Infection  and Autoimmunity, Y. Shoenfeld and N. R. Rose, eds. Amsterdam: Elsevier, 2004. 253-263.

Mack, C. L., C. L. Vanderlugt-Castaneda, K. L. Neville, and S. D. Miller.  “Microglia are activated to become competent antigen presenting cells and potent effector cells in the inflammatory environment of the Theiler’s virus model of multiple sclerosis.” J. Neuroimmunol. 144 (2003): 68-79.

Bradley E Theien, Carol L Castaneda-Vanderlugt, Cheryl Nickerson-Nutter, Mark Cornebise, Daniel M Scott, Stuart J Perper, Eric T Whalley, and Stephen D Miller.  “Differential effects of treatment with a small molecule anti-VLA-4  antagonist before and after onset of relapsing EAE.” Blood First Edition Paper, prepublished online August 21, 2003.

Vanderlugt, C. L. and S. D. Miller. “Role of Epitope Spreading in the Pathogenicity of Immune-Mediated Diseases: Implications for Specific Immunotherapy. Nature Reviews, Immunology 2 (2002),85-95.

Miller SD, Katz-Levy Y, Neville KL, VanderLugt CL.  “Virus-induced autoimmunity:  Epitope spreading to myelin autoepitopes in Theiler’s virus infection of the central nervous system.”  Advances in Virus Research  56 (2001), 199.

Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD.  “Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental encephalomyelitis. J. Clin. Invest. 107 (Apr 15, 2001),  995.

DalCanto MC, Calenoff MA, Miller SD, Vanderlugt CL. “Lymphocytes from mice chronically infected with Theiler’s murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein.  Epitope spreading in TMEV infection has functional activity.”  J Neuroimmunol. 104 (April 3, 2000), 79.

 Vanderlugt CL, Rahbe SM, Elliott PJ, Dalcanto MC, Miller SD. “Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.”  J Autoimmun. 14 (May, 2000), 205.

Haynes LM, Vanderlugt CL, DalCanto MC, Nelvoild RW, Miller SD.  “CD8+ T cells from Theiler’s virus-resistant BALB/cBYj mice downregulate pathogenic virus-specific CD4+ T cells.”  J Neuroimmunol. 106 (July 1, 2000), 43.

Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD. “CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.”  J. Neuroimmunol.  109 (Sept 22,2000), 173.

Katz-Levy Y, Nevelle KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD. “Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler’s virus-infected mice.”  J. Immunol. 165 (Nov 1, 2000), 5304.

VanderLugt, C. L., K. L. Neville, K. M Nikcevich, T. N. Eager, J. A. Bluestone, and S. D. Miller. “Pathologic role and temporal appearance of newly emerging autoepitopes in EAE.”  J. Immunology 164 (2000), 670.

Miller, S. D., Y. Katz-Levy, K. Neville, and C. L. Vanderlugt. “Virus-induced autoimmunity:  Epitope spreading to myelin autoepitopes in Theiler’s virus infection of the CNS.”  Adv Virus Res. 1999.

Katz-Levy, Y., K. L. Nevelle, A. M. Girvin, C. L. VanderLugt, J. G. Pope, L. J. Tan, and S. D. Miller.  “Endogenous processing of self myelin epitopes by CNS-resident APCs in Theiler’s virus-infected mice.”  J. Clin. Invest. 104 (1999), 599.

Howard, L. M., A. Miga, C. L. Vanderlugt, M. C. Dal Canto, J. D. Laman, R. J. Noelle, and S. D. Miller.  “Mechanisms of therapeutic intervention by anti-CD40L (CD154) in relapsing experimental autoimmune encephalomyelitis.”  J. Clin. Invest. 103 (1999), 281-290.

Nicholson, S. M., L. M. Haynes, C. L. Vanderlugt, S. D. Miller, and R. W. Melvold.  “CD8 Resistance to TMEV-induced demyelination in BalbC mice Does Not appear to be Based on CTL Activity.”  J. NeuroImmunology. 98 (1999), 136.

Vanderlugt, C. L., W.S Begolka, K. L. Neville, J. A. Bluestone, and S. D. Miller. “The functional significance of epitope spreading and its regulation by costimulatory interactions.”  Immunol. Rev. 164 (1998), 63.

Smith Begolka, W., C. L. Vanderlugt, S. M. Rahbe, and S. D. Miller.  “Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of MS.”  J. Immunol.161 (1998), 4437.

Karandidar, N. J., C. L. Vanderlugt, T. Eagar, L. Tan, J. A. Bluestone, and S. D. Miller. “Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.”  J. Immunol. 161 (1998), 192.

Karandikar*, N. J., C. L. Vanderlugt*, J. A. Bluestone†, and S. D. Miller*.  “Targeting the B7/CD28:CTLA-4 Costimulatory System In CNS Autoimmune Disease.” J Neuroimmunology 89 (1998), 10.

Chan, L. S., C. L. Vanderlugt, T. Hashimoto, T. Nishikawa, J. J. Zone, M. M. Black, F. Wojnarowska, S. R. Stevens, M. Chen, J. A. Fairley, D. T. Woodley, S. D. Miller, K. B. Gordon. “Epitope Spreading:  lessons from autoimmune skin diseases.”  J. Invest. Dermatology 110 (1998), 103-109.

Pope, J. G., C. L. Vanderlugt, H. L. Lipton, S. M. Rahbe, and S. D. Miller. “Characterization of and functional antigen presentation by CNS mononuclear cells from mice infected with Theiler’s murine encephalomyelitis virus.”  J. Virol. 72 (1998), 7762.

Tan, L. J., C. L. Vanderlugt, B. L. McRae, and S. D. Miller.  “Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.  III.  A role for clonal/deletion.”  Autoimmunity 27 (1998), 13-28.

Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, K. Neville, Y. R. L. Yauch, and B. S. Kim. “Persistent infection with Theiler’s Virus leads to CNS Autoimmunity Via Epitope Spreading.”  Nature Medicine 3 (1997), 1133-36.

Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. Neville, Y. Katz-Levy, and B. S. Kim.  “Epitope Spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler’s virus.”  J. Neurovirol. 3:Supp. 1 (1997),  S62.

Vanderlugt, C. L., N. J. Karandikar, D. J. Lenschow, M. C. Dal Canto, J. A. Bluestone*, and S. D. Miller*.  1997.  “Anti-B7-1 mAb Treatment Enhances Epitope Spreading and Exacerbates Relapses in R-EAE.”  J Neuroimmunology 79 (1997), 113-118. (*Co-senior authors)

Pope, J. G., W. J. Karpus, C. L. Vanderlugt, and  S. D. Miller. “Flow cytometric and functional analyses of CNS-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease:  Evidence for a CD4+ T cell-mediated pathology.”  J. Immunol.  156 (1996), 4050-58.

Karandikar, N. J., C. L. Vanderlugt, J. G. Pope, T. A. Walunas, J. A. Bluestone* and S. D. Miller*.  “CTLA-4:  A negative regulator of autoimmune disease.”  J. Exp. Med. 184 (1996), 783-788.  (*Co-senior authors)

Vanderlugt, C. L. and S. D. Miller.  “Epitope spreading.”  Curr. Opin. Immunol. 8 (1996), 831-36.

Miller, S. D., B. L. McRae, C. L. Vanderlugt, K. M. Nikcevich, J. G. Pope, L. Pope, and W. J. Karpus. “Evolution of the T cell repertoire during the course of experimental immune-mediated demyelinating diseases.”  Immunol. Rev.  144 (19950, 225-44.

Vanderlugt*, C. L., B. L. McRae*, M. C. Dal Canto, and S. D. Miller. “Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse.”  J. Exp. Med.  182 (1995), 75-85.  (*Co-first authors).

Vanderlugt*, C. L., S. D. Miller*, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. “Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE.”  Immunity.  3 (1995), 739-45.  (*Co-first authors).